Lv51
1290 积分 2021-05-28 加入
Modeling the PAX5P80R Mutation Reveals HIF2α Activation as a Common Feature and Therapeutic Target in B-cell Acute Lymphoblastic Leukemia
1小时前
待确认
SMARCA4 Loss Increases RNA Polymerase II Pausing and Elevates R-Loops to Inhibit BRCA1-Mediated Repair in Ovarian Cancer
1小时前
待确认
A phase I dose escalation and cohort expansion study of CB307, a trispecific Humabody® against PSMA, CD137, and albumin in patients with PSMA-positive solid tumors
1小时前
待确认
Targeting Innate Immune Checkpoint TREX1 Is a Safe and Effective Immunotherapeutic Strategy in Cancer
1小时前
待确认
Porustobart (HBM4003) plus Toripalimab as Second-Line Therapy in Patients with Advanced Hepatocellular Carcinoma: A Multicenter, Open-Label, Phase I Study
1小时前
待确认
Pharmacological inhibition of SIRT1 limits the growth of tumoral and metastatic granulosa cells by impacting mTOR, Myc and E2F pathways
1小时前
待确认
A Co-Clinical Trial of Exercise Therapy in Breast Cancer Prevention
1小时前
待确认
Epigenetic Regulation of Cellular Senescence in Gastrointestinal Cancer
1小时前
待确认
A PD-L1/CD3 BISPECIFIC ANTIBODY ENHANCES THE ANTI-TUMOR EFFECTS OF REGORAFENIB AGAINST COLON CANCER
1小时前
待确认
GANNET53 Part II: A European Phase I/II Trial of the HSP90 inhibitor Ganetespib in high-grade Platinum-Resistant Ovarian Cancer - A Study of the GANNET53 consortium
1小时前
待确认
皖公网安备34019202002308
